Supporting oncology professionals through education
The content on this site is intended for healthcare professionals only
The content on this site is intended for healthcare professionals only
Few studies have compared characteristics between breast cancers in men and women.
To evaluate whether hormone receptor-related gene expression differs between genders, researchers led by Danielle Zakon, MD, and Fraser Symmans, MD, evaluated 321 tumour RNA samples from men with early-stage HR-positive, HER2-negative breast cancer included in the retrospective cohort study of the EORTC 10085/BCG/TBCRC/BIG/NCTN International Male Breast Cancer Programme.
Using the sensitivity to endocrine therapy (SET2,3) index, developed by Symmans, they found gene expression measurements in male patients with breast cancer did not differ from those of female patients.
SET2,3 was prognostic for overall survival in male breast cancer and suggested that chemotherapy may improve the poor prognosis for men with breast cancer and a low SET2,3 index score.
The poster will be presented on December 7.
The World Cancer Declaration recognises that to make major reductions in premature deaths, innovative education and training opportunities for healthcare workers in all disciplines of cancer control need to improve significantly.
ecancer plays a critical part in improving access to education for medical professionals.
Every day we help doctors, nurses, patients and their advocates to further their knowledge and improve the quality of care. Please make a donation to support our ongoing work.
Thank you for your support.